The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(3,4-dichlorobenzyl)-4-oxo-3,4-dihydroquinazolin-6-yl)-2-hydroxyacetamide ID: ALA444433
PubChem CID: 25158453
Max Phase: Preclinical
Molecular Formula: C17H13Cl2N3O3
Molecular Weight: 378.21
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CO)Nc1ccc2ncn(Cc3ccc(Cl)c(Cl)c3)c(=O)c2c1
Standard InChI: InChI=1S/C17H13Cl2N3O3/c18-13-3-1-10(5-14(13)19)7-22-9-20-15-4-2-11(21-16(24)8-23)6-12(15)17(22)25/h1-6,9,23H,7-8H2,(H,21,24)
Standard InChI Key: ZZCPRLFJMWBCSV-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
-2.7167 -12.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7167 -13.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0046 -13.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0046 -11.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2926 -12.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2961 -13.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5874 -13.4424 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1294 -13.0352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1329 -12.2102 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5804 -11.7924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5780 -10.9674 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8496 -11.8015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5619 -12.2177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5554 -13.0427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2668 -13.4589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9845 -13.0501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9862 -12.2208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2741 -11.8084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4323 -11.7938 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.1456 -12.2084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8613 -11.7979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1432 -13.0333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.5745 -12.2125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7013 -11.8096 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.6973 -13.4654 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9 12 1 0
1 2 1 0
12 13 1 0
1 4 2 0
13 14 2 0
2 3 2 0
14 15 1 0
3 6 1 0
15 16 2 0
5 4 1 0
16 17 1 0
5 10 1 0
17 18 2 0
18 13 1 0
6 7 1 0
1 19 1 0
7 8 2 0
19 20 1 0
8 9 1 0
20 21 1 0
9 10 1 0
20 22 2 0
5 6 2 0
21 23 1 0
10 11 2 0
17 24 1 0
16 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 378.21Molecular Weight (Monoisotopic): 377.0334AlogP: 2.68#Rotatable Bonds: 4Polar Surface Area: 84.22Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.68CX Basic pKa: 4.65CX LogP: 2.30CX LogD: 2.30Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.73Np Likeness Score: -1.73
References 1. Koltun DO, Vasilevich NI, Parkhill EQ, Glushkov AI, Zilbershtein TM, Mayboroda EI, Boze MA, Cole AG, Henderson I, Zautke NA, Brunn SA, Chu N, Hao J, Mollova N, Leung K, Chisholm JW, Zablocki J.. (2009) Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors., 19 (11): [PMID:19394219 ] [10.1016/j.bmcl.2009.04.004 ] 2. Koltun DO, Zilbershtein TM, Migulin VA, Vasilevich NI, Parkhill EQ, Glushkov AI, McGregor MJ, Brunn SA, Chu N, Hao J, Mollova N, Leung K, Chisholm JW, Zablocki J.. (2009) Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors., 19 (15): [PMID:19577469 ] [10.1016/j.bmcl.2009.06.017 ] 3. Deng Y, Yang Z, Shipps GW, Lo SM, West R, Hwa J, Zheng S, Farley C, Lachowicz J, van Heek M, Bass AS, Sinha DP, Mahon CR, Cartwright ME.. (2013) Discovery of liver-targeted inhibitors of stearoyl-CoA desaturase (SCD1)., 23 (3): [PMID:23265904 ] [10.1016/j.bmcl.2012.11.075 ]